Buren advises ATS Automation Tooling Systems Inc. (“ATS”), an industry-leading automation solutions provider, on the Dutch law aspects of the acquisition of Comecer S.p.A. (“Comecer”). Comecer is a leader in the design, engineering, manufacture and servicing of advanced aseptic containment and processing systems for the nuclear medicine and pharmaceutical industries.
With the acquisition of Comecer, ATS will strengthen its customer offering in both pharma and biopharma, while adding an innovative new platform in radiopharmaceuticals. Comecer has subsidiaries in the Netherlands.
The total cash purchase price for the acquisition is 113 million Euro, subject to working capital and other adjustments. The transaction, which is subject to customary closing conditions, is expected to close in the first quarter of 2019.
In the wake of the developments concerning the COVID-19 / Coronavirus, BUREN has adjusted it’s policies to ensure that our services and
In the future, new rules will apply to Foreign Direct Investments (“FDI”) in the European Union and the Netherlands
Last month, the Netherlands Commercial Court (NCC) published its latest judgment.